952 related articles for article (PubMed ID: 20121368)
1. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
King JA; Armstrong D; Vachhrajani S; Dirks PB
J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
[TBL] [Abstract][Full Text] [Related]
2. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Moyamoya disease in the adult population with pial synangiosis.
Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
6. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
Jea A; Smith ER; Robertson R; Scott RM
Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
[TBL] [Abstract][Full Text] [Related]
7. Moyamoya disease and Moyamoya syndrome: experience in Europe; choice of revascularisation procedures.
Khan N; Schuknecht B; Boltshauser E; Capone A; Buck A; Imhof HG; Yonekawa Y
Acta Neurochir (Wien); 2003 Dec; 145(12):1061-71; discussion 1071. PubMed ID: 14663563
[TBL] [Abstract][Full Text] [Related]
8. [Pial synangiosis for moyamoya disease. The Bordeaux experience].
Jecko V; Penchet G; Champeaux C
Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323
[TBL] [Abstract][Full Text] [Related]
9. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.
Gadgil N; Lam S; Pyarali M; Paldino M; Pan IW; Dauser RC
J Neurosurg Pediatr; 2018 Nov; 22(5):541-549. PubMed ID: 30117790
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease.
Huang AP; Liu HM; Lai DM; Yang CC; Tsai YH; Wang KC; Yang SH; Kuo MF; Tu YK
Cerebrovasc Dis; 2009; 28(3):247-57. PubMed ID: 19602876
[TBL] [Abstract][Full Text] [Related]
11. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Hayashi T; Shirane R; Fujimura M; Tominaga T
J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
[TBL] [Abstract][Full Text] [Related]
12. Patients with moyamoya disease presenting with movement disorder.
Pandey P; Bell-Stephens T; Steinberg GK
J Neurosurg Pediatr; 2010 Dec; 6(6):559-66. PubMed ID: 21121731
[TBL] [Abstract][Full Text] [Related]
13. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
[TBL] [Abstract][Full Text] [Related]
14. Superficial temporal artery-middle cerebral artery bypass combined with encephalo-duro-myo-synangiosis in treating moyamoya disease: surgical techniques, indications and midterm follow-up results.
Xu B; Song DL; Mao Y; Gu YX; Xu H; Liao YJ; Liu CH; Zhou LF
Chin Med J (Engl); 2012 Dec; 125(24):4398-405. PubMed ID: 23253709
[TBL] [Abstract][Full Text] [Related]
15. Perfusion-weighted magnetic resonance imaging used in assessing hemodynamics following superficial temporal artery-middle cerebral artery bypass in patients with Moyamoya disease.
Li Z; Zhou P; Xiong Z; Ma Z; Wang S; Bian H; Chen J
Cerebrovasc Dis; 2013; 35(5):455-60. PubMed ID: 23735877
[TBL] [Abstract][Full Text] [Related]
16. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of one-stage direct revascularization and medicine therapy for treatment of ischemic moyamoya disease].
Zhao H; You C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Sep; 23(9):1097-100. PubMed ID: 19817297
[TBL] [Abstract][Full Text] [Related]
18. Clinical and angiographic outcomes from indirect revascularization surgery for Moyamoya disease in adults and children: a review of 63 procedures.
Dusick JR; Gonzalez NR; Martin NA
Neurosurgery; 2011 Jan; 68(1):34-43; discussion 43. PubMed ID: 21150753
[TBL] [Abstract][Full Text] [Related]
19. Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.
Fujimura M; Shimizu H; Mugikura S; Tominaga T
Surg Neurol; 2009 Feb; 71(2):223-7; discussion 227. PubMed ID: 18291489
[TBL] [Abstract][Full Text] [Related]
20. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
